MD Anderson Cancer Center and 4D pharma collaborate to evaluate live biotherapeutics in solid tumors

(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D's live biotherapeutic oncology pipeline across a range of cancer settings.